← Back to all earnings calls

Sutro Biopharma, Inc. Q1 FY2026 Earnings Call

Sutro Biopharma, Inc. (STRO)

Earnings Call FY2026 Q1 Call date: 2026-05-27 Concluded

Share

Quarter scorecard

Revenue

$14.52M

-16.5% YoY

Diluted EPS

$-2.94

Net income

-$38.48M

Documents & deck